Bilateral bacterial keratitis after laser in situ keratomileusis in a patient with human immunodeficiency virus infection.
J A
JA
Hovanesian
E G
EG
Faktorovich
J D
JD
Hoffbauer
S S
SS
Shah
R K
RK
Maloney
D002437:Cefazolin / Q000627:therapeutic use; D003315:Cornea / Q000601:surgery; D016039:Corneal Transplantation; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D015817:Eye Infections / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007634:Keratitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D015948:Keratoplasty, Penetrating; D053685:Laser Therapy / Q000009:adverse effects*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009216:Myopia / Q000601:surgery; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification*; D014031:Tobramycin / Q000627:therapeutic use
D002437:Cefazolin; D014031:Tobramycin